An interesting study looking at using a deep learning model to evaluate ECGs in the emergency room to determine if patients need coronary revascularization as existing methods can sometimes be inconclusive. academic.oup.com/eurheartj/ad...

Tomorrow is your last chance to visit this BP measurement learning station at #ACC25! Avoiding common pitfalls is key to accurate care—don’t miss it in the Personalized Skills Center. learn.acc.org/Page/LEARNHTN #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

ALPACA: The novel extended-duration small interfering RNA lepodisiran reduced mean serum concentrations of Lp(a) from 60 to 180 days after being administered subcutaneously. #ACC25 Learn more about the study ➡️ bit.ly/3Y1DkU7 #CardioSky #MedSky

Dr. Victor Dzau presenting his keynote speech, Science, Medicine, and Society: A Brave New World, during the 2025 Eugene Braunwald Keynote happening now! 📍Room S100b #ACC25 #CardioSky

FRESH-UP Trial #ACC25 #medsky RCT comparing liberal vs restricted fluid intake (≤1500 ml/d) in 504 pts with stable chronic HF 🌊No difference in status health quantified by Kansas City Cardiomyopathy Questionnaire at 3 mths 🌊 More thirst distress with restriction www.nature.com/articles/s41...

Dr. Victor Dzau: How do we improve #cvd with rising #obesity? ✅Start with 1° and 2° #cvprev ✅Primordial prevention @accintouch.bsky.social #acc25

Dr. Victor Dzau: Future of #CVD care is going to be evolving rapidly over the next century: ❤️ Emphasis on prevention ❤️ Equitable access and affordable ❤️ Mission-based innovation ❤️ Develop national priorities Need governance to oversee innovation, ensure ethics #acc25 @accintouch.bsky.social

Wellstar team-based care in action at #ACC25! This poster showcases a coordinated strategy to improve SGLT2i use post-AMI—driving better prescribing, education, and follow-up for patients. #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

FRESH-UP at #ACC25: No benefit to fluid restriction in HF. No harm with liberal intake. Improved QOL with more fluid freedom. Supports what we have long suspected—and may help shift the standard of care moving forward. #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

#ACC25 #LGBTQ work group represents at the Health #Equity Hub! Dr Deb and Dr Coylewright - So proud of the work you’re both doing! @thornsberryjd.bsky.social @brototod.bsky.social

Join us for this exciting session on management of CIEDs in complex patients - #ACC25 #CIED #cardiopalli #SDM @accintouch.bsky.social @thornsberryjd.bsky.social

EquiOx at #ACC25 confirms it: pulse oximeters don’t perform equally across skin tones—especially critically ill patients Wellstar’s, Dr. Paul Douglass shared insight on the need for equity in device validation #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

MIGHTy-Heart took on gaps in HF care transitions. ✴️ 2,003 enrolled → MIH vs. TOCC ✴️ No difference in 30-day outcomes ✴️ Younger patients & women saw more benefit. Impressive representation: 52% women, 47% Black #ACC25 #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

🔥Hot off the press: Highlights from day 1 at #ACC25 #CardioSky 📌 WARRIOR 📌 STRIDE 📌 API-CAT 📌 SOUL 📌 RIVAWAR 📌 & more in the link www.healio.com/news/cardiol...

Among persons with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both, oral semaglutide was associated with a significantly lower risk of major adverse cardiovascular events than placebo #MedSky #CardioSky #NephSky www.nejm.org/doi/full/10....

More from day 1 #ACC25 … 📌 WARRIOR = the largest study of women with suspected ischemia with nonobstructive coronary disease 📌 Intensive medical therapy did not prevent 🫀 events for women with INOCA 📌 “This trial should not be considered a negative trial” www.healio.com/news/cardiol...

#ACC25 #Palliative Workgroup Huddle! So much creativity and compassion - and WORK - in the this group! #ACCGeriatric #ACCFIT #ACCCVT @accintouch.bsky.social @shummelmd.bsky.social @thornsberryjd.bsky.social

Join us for a fun #CardioObstetrics session at #ACC25 #CardioSky 📅 Sun, Mar 30 ⏰ 10AM @accintouch.bsky.social @mdharringtonc.bsky.social @drklindley.bsky.social @abraguo.bsky.social @garimasharmamd.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @thornsberryjd.bsky.social

Join us now for #ACC25 #CardioObstetrics Meet-Up @accintouch.bsky.social @mdharringtonc.bsky.social @drklindley.bsky.social

Today at 4:30PM Don’t miss #ACC25 #CardioObstetrics Meet-Up

📆 Mark your calendars for Monday at #ACC25! Wellstar MCG presents a high-stakes case: RotaWire entrapment, fracture, and retrieval—titled “When It Rains It Pours.” ☔️💙 You won’t want to miss this one! #WellstarCVteam #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social

An oral formulation of semaglutide lowered the risk major adverse cardiovascular events by 14% in four years, with no change in safety profile compared to placebo, according to the SOUL study. #ACC25 Read the journal scan to learn more: bit.ly/3QTpizK #CardioSky #MedSky

DAPA-TAVI: The #SGLT2 inhibitor dapagliflozin was superior to standard care alone in decreasing rates of all-cause mortality or worsening #HeartFailure in older adults w/ #vhdAS undergoing TAVI, resulting in a 28% relative risk ↘️. #ACC25 More: bit.ly/4cfLNsy #cvSurg #CardioSky #MedSky

In SOUL, 2596/9650 (26.9%) participants were receiving SGLT2i at baseline (largest CVOT of combined GLP-1/SGLT2 to date) The effect of oral semaglutide on cardiovascular outcomes was consistent, regardless of SGLT2i use #ACC25 www.ahajournals.org/doi/abs/10.1...

#equity in heart care. Yes. ❤️ #ACC25 #ACCCVT

Learn more about ACC's NP/PA #CCKE: bit.ly/3oOmx80 #ACC25 #CardioSky #MedSky

Key takeaways from the CCKE for NPs & PAs session at #ACC25: • More than a test—it’s a career milestone • Prep with purpose, not panic • Exam day success = strategy + mindset #Cardiology #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

Hard to do a clinical trial during a pandemic + suboptimal adherence and contamination but good to see a focus on women!

WARRIOR: A neutral trial, but key insights for women with INOCA. 🔹 2,476 enrolled (60% target) 🔹 High angina burden 🔹 SBP ≤120 mmHg may reduce angina 🔹 Future potential with ACEI/ARB + statins #ACC25 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

📸 Dr. Douglass on the big screen at #ACC25! As Chair of the ACC Task Force on Health Equity, his leadership is moving us closer to true equity in heart care. 💙 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

Science is booming at #ACC25 —17% more submissions than past years! 50+ clinical trial sessions, including late-breakers and featured research. Next up: • WARRIOR • STRIDE • API-CAT #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

Inspiring #ACC25 keynote by Cathleen Biga: 🫀 Embrace lifelong learning, AI, and health equity. 🫀 Protect patient access. 🫀 Honor those before us by writing the future—together. #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

👊🏻 Powerful start to #ACC25 with ACC President Cathleen Biga’s message: Embrace the CV team. Transform heart health for all. Grateful to witness leadership that champions collaboration and equity. #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

📣 The doors are open—ACC.25 has officially begun! Kicking things off with the Opening Showcase, featuring Cathleen Biga & Kathryn Berlacher. Let’s make it a weekend to remember! #ACC25 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

Artie’s all packed—are you? 🎒 📱 #ACC25 App ✅ Pro Tip: Make sure to download the app & set ⏰ for your must-attend sessions! 💻 Laptop/Notebook ✅ 👟 Comfy Shoes ✅ 💙 ACC Blue for March 31 ✅ ⚡️ Excitement & Energy! ✅ 4️⃣ days to go! What's your must-have for ACC.25? 🤔 #CardioSky #MedSky

Whether intensive systolic blood-pressure control or standard control is better for cardiovascular risk reduction in patients with type 2 #diabetes has been unclear. Research findings are summarized in a new Quick Take video. youtu.be/5FxxqoUFaac #MedSky #CardioSky

💡 Dr. Sandra Oliver-McNeil highlights 🔑 markers of quality research design: 🔹What types of studies are being conducted? 🔹Is the data free from bias? 🔹Were variables and confounding factors properly studied? 🔹Are the results valid and reliable? #ACC25 #JACC

The energy was high diving into Hands-on Workshop 1 right after Dr. Oliver-McNeil’s presentation! You’re already tackling a #JACC #TAVR clinical case, applying real-world insights and enhancing your skills 💡 #ACC25 @vivekkulkarni.bsky.social

#ACCCVT - here’s one not to miss! #ACCWIC #ACC25

See what's happening at the #AHAJournals! #ACC25 Sign up for alerts for the Switchboard blog at AHAJournals.org #Cardiosky

#ACC25 ACPC Community day @accintouch.bsky.social

Breakouts Difficult discussions best practices #ACC25

I’m thrilled to be a #ACC25 Social Media Ambassador! Follow me for live Cardiovascular Team Section updates. See you in Chicgo!! #ACCCVT #ACC25

Want to crush #ACC25? 📲 Download the ACC.25 mobile app! It’s your hub for sessions, schedules & networking. Let’s make this the most connected conference yet! 💙 apps.apple.com/us/app/acc-2... #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

✈️ Hello from McCormick Place! #ACC25 is about to kick off and I’m here as a Social Media Ambassador—ready to soak in every moment. Let’s make this unforgettable! 💙 #ACCCVT #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social

List of #ACC25 SoMe Ambassadors bsky.app/profile/did:... @bakhshihooman.bsky.social @cathlabedu.bsky.social @thornsberryjd.bsky.social @saraersozlu.bsky.social @accintouch.bsky.social

Reposting this for #ACC25 Pls “REPOST” if you like to share a post with others #CardioSky @anastasiasmihaili.bsky.social @drmarthagulati.bsky.social @cathlabedu.bsky.social @thornsberryjd.bsky.social @saraersozlu.bsky.social @vietheartpa.bsky.social @drmonalidesai.bsky.social

💙 #ACC25 will unveil groundbreaking trials that will reshape cardiovascular care. Don't miss the research that could shift guidelines & improve outcomes! 🔗 Late-Breakers: accscientificsession.acc.org/en/Plan-Your... #ACC25 #ACCCVT #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social

Getting ready for #ACC25? ✅ Download #ACC25 app apps.apple.com/us/app/acc-2... ✅ Follow #ACC25 ambassadors bsky.app/profile/did:... #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social @saraersozlu.bsky.social @thornsberryjd.bsky.social @cathlabedu.bsky.social @bakhshihooman.bsky.social